4//SEC Filing
Friedman Franklin Stuart 4
Accession 0000950170-24-005390
CIK 0001654151other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:15 PM ET
Size
5.6 KB
Accession
0000950170-24-005390
Insider Transaction Report
Form 4
Friedman Franklin Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-16$10.58/sh+4,727$50,004→ 4,727 totalExercise: $14.46Exp: 2034-01-15→ Common Stock (4,727 underlying)
Footnotes (1)
- [F1]These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2024 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001794351
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:15 PM ET
- Size
- 5.6 KB